Loading...

Bruker Corporation

BRKRNASDAQ
Healthcare
Medical - Devices
$41.94
$1.49(3.68%)

Bruker Corporation (BRKR) Stock Overview

Explore Bruker Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.9/100

Key Financials

Market Cap6.4B
P/E Ratio79.57
EPS (TTM)$0.52
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Week$37.67
1 Month$36.79
3 Months$34.13
1 Year Target$62.16

BRKR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bruker Corporation (BRKR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.37, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $62.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 79.57 and a market capitalization of 6.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;